Skip to search formSkip to main contentSkip to account menu

amp 579

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Inhibitory effects of AMP 579, a novel cardioprotective adenosine A1/A2A receptor agonist, on native IKr and cloned HERG current
We investigated the effects of 1S-[1a,2b,3b,4a(S*)]-4-[7-[[1-[(3-chloro-2-thienyl)methylpropyl]propyl-amino]-3H-imidazo[4,5-b… 
2001
2001
Attenuation of oxidant stress during reoxygenation by AMP 579 in cardiomyocytes.
AMP 579, an adenosine A(1)/A(2) receptor agonist, has a strong anti-infarct effect when administered just before reperfusion… 
2001
2001
Protective effect of AMP 579 depends on drug's timing of administration and can be added to that of ischemic preconditioning
2000
2000
Pharmacokinetics and Safety of Single Intravenous Infusions of the Adenosine Agonist, AMP 579, in Patients with End‐Stage Renal Insufficiency
The pharmacokinetics of an adenosine agonist (AMP 579) were characterized in patients with end‐stage renal disease compared to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)